Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments William V. PadulaR. Brett McQueen Editorial Open access 05 October 2019 Pages: 757 - 759
A Framework to Prioritise Health Research Proposals for Funding: Integrating Value for Money Haitham W. TuffahaJoanne AitkenPaul A. Scuffham Practical Application 01 July 2019 Pages: 761 - 770
A Review of Recent Decision-Analytic Models Used to Evaluate the Economic Value of Cancer Treatments Ash BullementHolly L. CranmerGemma E. Shields Review Article Open access 04 September 2019 Pages: 771 - 780
A Review of the Development and Application of Generic Preference-Based Instruments with the Older Population Jenny ClelandClaire HutchinsonJulie Ratcliffe Review Article 12 September 2019 Pages: 781 - 801
Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries Sabine VoglerGuillaume DedetHanne Bak Pedersen Original Research Article 11 September 2019 Pages: 803 - 816
The Value Employees Place on Health Insurance Plans: A Discrete-Choice Experiment Stephen PoteetBenjamin M. Craig Original Research Article 19 August 2019 Pages: 817 - 825
Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting Gabriel TremblayBen RousseauJosée Hébert Original Research Article Open access 07 August 2019 Pages: 827 - 839
Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial Marcel BilgerTina T. WongEric A. Finkelstein Original Research Article Open access 18 July 2019 Pages: 841 - 855
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands Renée Else MichelsMaria de FransescoMarieke Krol Original Research Article Open access 23 August 2019 Pages: 857 - 873
In-Hospital Healthcare Utilization, Outcomes, and Costs in Pre-Hospital-Adjudicated Low-Risk Chest-Pain Patients Dominique N. van DongenJan Paul OttervangerRobbert J. Slingerland Original Research Article 06 August 2019 Pages: 875 - 882
Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia Rick A. VremanJoost W. GeenenMaiwenn J. Al Original Research Article Open access 18 July 2019 Pages: 883 - 893
What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population Kim PauwelsIsabelle HuysSteven Simoens Original Research Article Open access 30 July 2019 Pages: 895 - 902